Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

South Korea flag South Korea · Delayed Price · Currency is KRW
30,300
+400 (1.34%)
At close: Dec 5, 2025
13.70%
Market Cap 178.16B
Revenue (ttm) 209.00B
Net Income (ttm) 31.56B
Shares Out 5.88M
EPS (ttm) n/a
PE Ratio 5.65
Forward PE 5.85
Dividend 900.00 (3.01%)
Ex-Dividend Date Dec 29, 2025
Volume 9,917
Average Volume 17,228
Open 29,900
Previous Close 29,900
Day's Range 29,650 - 30,300
52-Week Range 24,750 - 33,950
Beta 0.20
RSI 53.49
Earnings Date Mar 18, 2026

About Daihan Pharmaceutical

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1945
Employees 553
Stock Exchange KOSDAQ
Ticker Symbol 023910
Full Company Profile

Financial Performance

In 2024, Daihan Pharmaceutical's revenue was 204.19 billion, an increase of 4.23% compared to the previous year's 195.91 billion. Earnings were 33.76 billion, an increase of 18.76%.

Financial Statements

News

There is no news available yet.